XORTX Therapeutics Inc.(XRTX US)
$1.10+0.1819.57%
- Pricing and plans
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
Get the full experience
We save the real magic for signed-in users.
| Millions CAD (ex. Per Share) | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | |||||||||||
| -Cost of Revenue | 0.2 | 0.2 | 0.2 | 0.1 | |||||||||||
| Gross Profit | -0.2 | -0.2 | -0.2 | -0.1 | |||||||||||
| -Operating Expenses | 6.9 | 5.5 | 4.6 | 4.4 | |||||||||||
| +Selling, General & Admin | 3.4 | 5.2 | 2.6 | 2.8 | |||||||||||
| +General And Administrative Expenses | 1.5 | 1.6 | 2.6 | 2.8 | |||||||||||
| +Selling And Marketing Expenses | 2.5 | 1.7 | - | — | |||||||||||
| +Research and Development | 3.4 | 0.3 | 0.8 | 0.5 | |||||||||||
| +Other Operating Expenses | - | - | 1.2 | 1.2 | |||||||||||
| Operating Income | -6.9 | -5.6 | -4.6 | -4.4 | |||||||||||
| +Non Operating Income | 2.8 | 1.3 | 0.9 | 0.5 | |||||||||||
| +Interest Income, Net | - | 0.2 | 0.1 | 0.0 | |||||||||||
| +Interest Income | 0.5 | 0.2 | 0.1 | 0.0 | |||||||||||
| -Interest Expense | - | - | - | - | |||||||||||
| +Other Non-Op Income | 2.8 | 1.1 | 0.9 | 0.5 | |||||||||||
| Pretax Income | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Income Tax Expense | - | - | - | - | |||||||||||
| Income from Cont Ops | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||
| +Discounted operations | - | - | - | - | |||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||
| Income Incl. MI | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Minority Interests | - | - | - | - | |||||||||||
| Net Income, GAAP | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||
| Net Income Avail To Common | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| Weighted Average Shs Out | 79,270 | 115,140 | 189,385 | 622,144 | |||||||||||
| EPS | -51.4 | -39.5 | -20.3 | -97.6 | |||||||||||
| Weighted Average Shs Out Dil | 79,270 | 115,140 | 189,385 | 622,144 | |||||||||||
| EPS Diluted | -51.4 | -39.5 | -20.3 | -97.6 | |||||||||||
| Millions CAD (ex. Per Share) | FY201412/31/2014 | FY201512/31/2015 | FY201612/31/2016 | FY201712/31/2017 | FY201812/31/2018 | FY201912/31/2019 | FY202012/31/2020 | FY202112/31/2021 | FY202212/31/2022 | FY202312/31/2023 | FY202412/31/2024 | FY202512/31/2025 | Last 12M03/31/2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | |||||||||||
| -Cost of Revenue | 0.2 | 0.2 | 0.2 | 0.1 | |||||||||||
| Gross Profit | -0.2 | -0.2 | -0.2 | -0.1 | |||||||||||
| -Operating Expenses | 6.9 | 5.5 | 4.6 | 4.4 | |||||||||||
| +Selling, General & Admin | 3.4 | 5.2 | 2.6 | 2.8 | |||||||||||
| +General And Administrative Expenses | 1.5 | 1.6 | 2.6 | 2.8 | |||||||||||
| +Selling And Marketing Expenses | 2.5 | 1.7 | - | — | |||||||||||
| +Research and Development | 3.4 | 0.3 | 0.8 | 0.5 | |||||||||||
| +Other Operating Expenses | - | - | 1.2 | 1.2 | |||||||||||
| Operating Income | -6.9 | -5.6 | -4.6 | -4.4 | |||||||||||
| +Non Operating Income | 2.8 | 1.3 | 0.9 | 0.5 | |||||||||||
| +Interest Income, Net | - | 0.2 | 0.1 | 0.0 | |||||||||||
| +Interest Income | 0.5 | 0.2 | 0.1 | 0.0 | |||||||||||
| -Interest Expense | - | - | - | - | |||||||||||
| +Other Non-Op Income | 2.8 | 1.1 | 0.9 | 0.5 | |||||||||||
| Pretax Income | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Income Tax Expense | - | - | - | - | |||||||||||
| Income from Cont Ops | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Net Extraordinary Losses | - | - | - | - | |||||||||||
| +Discounted operations | - | - | - | - | |||||||||||
| +XO & Accounting Changes | - | - | - | - | |||||||||||
| Income Incl. MI | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Minority Interests | - | - | - | - | |||||||||||
| Net Income, GAAP | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| -Prfrrd Div & Other | - | - | - | - | |||||||||||
| Net Income Avail To Common | -4.1 | -4.5 | -3.8 | -3.9 | |||||||||||
| Weighted Average Shs Out | 79,270 | 115,140 | 189,385 | 622,144 | |||||||||||
| EPS | -51.4 | -39.5 | -20.3 | -97.6 | |||||||||||
| Weighted Average Shs Out Dil | 79,270 | 115,140 | 189,385 | 622,144 | |||||||||||
| EPS Diluted | -51.4 | -39.5 | -20.3 | -97.6 | |||||||||||